SOW
SUPN icon

State of Wyoming’s Supernus Pharmaceuticals SUPN Stock Holding History

State of Wyoming’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Sell
2,873
-3,768
-57% -$192K 0.02% 1109
2025
Q4 		$330K Buy
6,641
+5,218
+367% +$254K 0.04% 656
2025
Q3 		$68K Buy
+1,423
New +$57.3K 0.01% 1433
2025
Q2 		– Sell
-4,754
Closed -$156K – 2096
2025
Q1 		$156K Buy
4,754
+1,761
+59% +$62.4K 0.02% 950
2024
Q4 		$108K Sell
2,993
-65
-2% -$2.29K 0.01% 1138
2024
Q3 		$95.3K Buy
3,058
+265
+9% +$8.27K 0.01% 1185
2024
Q2 		$74.7K Buy
2,793
+309
+12% +$8.96K 0.01% 1198
2024
Q1 		$84.7K Sell
2,484
-161
-6% -$4.79K 0.01% 1110
2023
Q4 		$76.5K Sell
2,645
-792
-23% -$21K 0.01% 1175
2023
Q3 		$94.8K Sell
3,437
-2,511
-42% -$76.4K 0.02% 892
2023
Q2 		$179K Buy
5,948
+22
+0.4% +$770 0.05% 450
2023
Q1 		$215K Sell
5,926
-395
-6% -$15.2K 0.07% 292
2022
Q4 		$225K Buy
6,321
+2,569
+68% +$89.3K 0.08% 249
2022
Q3 		$127K Sell
3,752
-1,575
-30% -$51.3K 0.06% 460
2022
Q2 		$154K Buy
5,327
+1,931
+57% +$55.3K 0.1% 244
2022
Q1 		$110K Buy
3,396
+1,261
+59% +$38.7K 0.06% 531
2021
Q4 		$62K Sell
2,135
-63
-3% -$1.91K 0.03% 988
2021
Q3 		$59K Buy
2,198
+366
+20% +$9.82K 0.04% 708
2021
Q2 		$56K Buy
+1,832
New +$56.2K 0.04% 717

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wyoming's SUPN Position: Q1 2026 in Review

State of Wyoming reduced its Supernus Pharmaceuticals (SUPN) stake by 57% in Q1 2026, selling an estimated $192K and leaving 2,873 shares worth $149K. The position accounts for 0.02% of the portfolio, ranked #1109.

State of Wyoming first reported a position in SUPN in Q2 2021 and has held it in 19 quarters since. The position peaked at $330K in Q4 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • State of Wyoming held 2,873 shares of Supernus Pharmaceuticals worth $149K as of Q1 2026.
  • State of Wyoming sold 3,768 Supernus Pharmaceuticals shares in Q1 2026, an estimated $192K.
  • Supernus Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q1 2026, its #1109 holding.
  • State of Wyoming first reported a position in Supernus Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • State of Wyoming's Supernus Pharmaceuticals position peaked at $330K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.